Swine flu patients benefited from taking Tamiflu, says study

Sep 29, 2010

Healthy people who caught swine flu during the 2009 pandemic may have been protected against developing radiographically (x-ray) confirmed pneumonia by taking the antiviral drug oseltamivir (Tamiflu), concludes a study of cases in China published in the British Medical Journal today.

The researchers also show that oseltamivir treatment was associated with shorter duration of fever and viral RNA shedding (the period when a virus is contagious), although they stress that their findings should be interpreted with caution.

In 2009, A (H1N1) virus spread rapidly, resulting in millions of cases and over 18,000 deaths in over 200 countries.

Trials carried out on seasonal flu viruses have shown that taking antiviral drugs within 48 hours of symptom onset can reduce the severity and duration of symptoms, and possibly the risk of complications.

However, the extent to which antivirals may benefit otherwise healthy individuals with mild 2009 H1N1 infection, remains unknown.

So researchers reviewed the medical records of 1,291 patients in China with laboratory confirmed mild H1N1 infection during the 2009 pandemic.

The average age of patients was 20 years. Three quarters (76%) were treated with oseltamivir from a median of the third day of symptoms. Of 920 patients who had a chest x-ray, a minority (12%) had abnormal findings consistent with pneumonia.

No patients required admission or mechanical ventilation.

Using statistical modelling of the patients' data, the researchers ruled out the effects of age, sex, influenza vaccination, and treatment with antibiotics on the main study outcomes: getting pneumonia, having prolonged high fever, and viral RNA shedding. Oseltamivir treatment was then identified as a significant protective factor against subsequent development of pneumonia, confirmed by a chest x-ray. This protective effect was seen in all patients including those who started treatment more than two days after onset of symptoms.

Oseltamivir treatment started within two days of symptom onset also reduced the duration of fever and viral RNA shedding, they add. They also found that 2009 H1N1 might be shed longer than seasonal influenza virus.

These findings are consistent with patients with the 2009 H1N1 benefiting from use of oseltamivir, conclude the authors. However, they stress that their finding that treatment protected against subsequent radiographic pneumonia should be interpreted with caution, given the retrospective design of this work and the fact that not all patients underwent a chest x-ray.

They call for continued investigation into the effectiveness of antiviral treatment "to allow for improvement both in clinical treatment and public health guidance."

Explore further: Ebola isolation at US base 'pretty much vacation'

add to favorites email to friend print save as pdf

Related Stories

Drug-resistant swine flu cluster on Vietnam train

Dec 09, 2009

(PhysOrg.com) -- A cluster of seven people infected with a Tamiflu-resistant strain of pandemic H1N1 influenza has been identified in Vietnam by a team including Oxford researchers.

H1N1 influenza hits older children

May 04, 2010

Children hospitalized with pandemic H1N1 influenza in 2009 were older and more likely to have underlying medical conditions than children hospitalized with seasonal influenza during prior flu seasons, according to a study ...

Recommended for you

Ebola isolation at US base 'pretty much vacation'

4 minutes ago

With plenty of flat screen TVs, game nights and even an outdoor fire pit, life in isolation for members of the U.S. military who have returned from the Ebola mission in West Africa can look a lot like summer camp.

Chinese-built Ebola center dedicated in Liberia

3 hours ago

China, one of the first countries to send aid to battle Ebola in West Africa, ramped up the assistance significantly Tuesday by opening a 100-bed treatment center in Liberia as rows of uniformed Chinese army ...

Superbug in SE Michigan shows recent decline

6 hours ago

A new study finds a decrease in an emergent strain of methicillin-resistant S. aureus (MRSA) that is resistant to last line defense antibiotics. Researchers examined the prevalence of vancomycin-resistant Staphylococcus aureus (V ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.